Part of a stock price is future potential at this early stage. Valuations on the OTC are usually not realistic, where companies that generate negative cash flow for years with zero hope of ever becoming profitable have billion dollar valuations.
Bottom line - you have to determine the amount of weight you place on realistic valuations. For me this new sector will produce some unicorns - I think CVSI is one of them. I think CVSI and CWBHF will be the Microsoft and Apple of CBD.
I'm perfectly happy with CVSI hitting 5-10 billion valuation, I only need it there for 1 day so I can sell and change my life. I know sky high valuations wont last....but current valuation is too low imo. Once all the frivilous lawsuits get dismissed we should see another major bump.
It is only a 9.27 price to sales ratio with $63.1 million TTM with 21.4 sales for 3Q18 which matches 200% y/y change like last quarter 2Q
At the same price ratio as 2Q -11.64 P to S ratio then current price-per share is estimated at $10.95 -YEA based on 21.4 3q sales and 85.6 Annualized Sales Run Rate- note this is more reasonable based on growing new business etc.
Reasonable price target is $10.95 per-share or about 50% UP from here after quarterly numbers released